Olivia Newton-John Cancer Research Institute

OrgUnit's Researchers
(Persons)

Results 1-5 of 36 (Search time: 0.002 seconds).

FullnameTranslated NameEmail
Afshar-Sterle, ShoukatSkoukat.AFSHAR-STERLE@austin.org.au
Allan, Laura CLaura.Allan@onjcri.org.au
Anderson, Robin Lrobyn.anderson@austin.org.au
Ayati, Narjessnarjess.ayati@austin.org.au
Barraclough, AllisonAllison.BARRACLOUGH@austin.org.au

OrgUnit's Researchers publications
(Dept/Workgroup Publication)

Results 241-260 of 931 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
2411-Sep-1998Direct immobilization of gangliosides onto gold-carboxymethyldextran sensor surfaces by hydrophobic interaction: applications to antibody characterization.Catimel, B; Scott, Andrew M ; Lee, Fook-Thean; Hanai, N; Ritter, G; Welt, S; Old, Lloyd J; Burgess, Antony W; Nice, Edouard C
2421-Jun-2006Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.Nicholaou, Theo; Ebert, Lisa; Davis, Ian D; Robson, Neil; Klein, Oliver ; Maraskovsky, Eugene; Chen, Weisan; Cebon, Jonathan S 
2432021Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer.Lee, Erinna F; Fairlie, Walter Douglas 
24424-Jun-2020Distinctive subpopulations of stromal cells are present in human lymph nodes infiltrated with melanoma.Eom, Jennifer; Park, Saem Mul; Feisst, Vaughan; Chen, Chun-Jen J; Mathy, Joanna E; McIntosh, Julie D; Angel, Catherine E; Bartlett, Adam; Martin, Richard; Mathy, Jon A; Cebon, Jonathan S ; Black, Michael A; Brooks, Anna E S; Dunbar, P Rod
2452018Divergent T-cell receptor recognition modes of a HLA-I restricted extended tumour-associated peptide.Chan, Kok Fei; Gully, Benjamin S; Gras, Stephanie; Beringer, Dennis X; Kjer-Nielsen, Lars; Cebon, Jonathan S ; McCluskey, James; Chen, Weisan; Rossjohn, Jamie
24628-Aug-2020Diversity in the intrinsic apoptosis pathway of nematodes.Young, Neil D; Harris, Tiffany J ; Evangelista, Marco; Tran, Sharon; Wouters, Merridee A; Soares da Costa, Tatiana P; Kershaw, Nadia J; Gasser, Robin B; Smith, Brian J; Lee, Erinna F; Fairlie, Walter Douglas 
247Oct-2017DNA Breathing Enables Closed-Tube Mutant Allele Enrichment for Circulating Tumor DNA Analysis.Dobrovic, Alexander 
2481-Oct-2014DNA ligase-based strategy for quantifying heterogeneous DNA methylation without sequencing.Wee, Eugene J H; Rauf, Sakandar; Shiddiky, Muhammad J A; Dobrovic, Alexander ; Trau, Matt
24928-Aug-2018DNA Methylation Profiling of Breast Cancer Cell Lines along the Epithelial Mesenchymal Spectrum-Implications for the Choice of Circulating Tumour DNA Methylation Markers.Le, Anh Viet-Phuong; Szaumkessel, Marcin; Tan, Tuan Zea; Thiery, Jean-Paul; Thompson, Erik W; Dobrovic, Alexander 
25014-Feb-2013Docetaxel plus cetuximab as second-line treatment for docetaxel-refractory oesophagogastric cancer: the AGITG ATTAX2 trial.Tebbutt, Niall C ; Parry, M M; Zannino, D; Strickland, A H; Van Hazel, G A; Pavlakis, N; Ganju, V; Mellor, D; Dobrovic, Alexander ; Gebski, V J
25128-Nov-2020Donor-specific cell-free DNA as a biomarker in liver transplantation: A review.McClure, Tess ; Goh, Su Kah ; Cox, Daniel R A ; Muralidharan, Vijayaragavan ; Dobrovic, Alexander ; Testro, Adam G 
252Mar-2019Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care.Casan, Joshua Ml; Barraclough, Allison ; Shortt, Jake; Hawkes, Eliza A 
25329-Jan-2021Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study.Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C 
25415-Apr-2021Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study.Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy J; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C 
255Apr-2022Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial.Aggarwal, Charu; Prawira, Amy; Antonia, Scott; Rahma, Osama; Tolcher, Anthony; Cohen, Roger B; Lou, Yanyan; Hauke, Ralph; Vogelzang, Nicholas; P Zandberg, Dan; Kalebasty, Arash Rezazadeh; Atkinson, Victoria; Adjei, Alex A; Seetharam, Mahesh; Birnbaum, Ariel; Weickhardt, Andrew J ; Ganju, Vinod; Joshua, Anthony M; Cavallo, Rosetta; Peng, Linda; Zhang, Xiaoyu; Kaul, Sanjeev; Baughman, Jan; Bonvini, Ezio; Moore, Paul A; Goldberg, Stacie M; Arnaldez, Fernanda I; Ferris, Robert L; Lakhani, Nehal J
256Jun-2016Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.Tögel, Lars; Nightingale, Rebecca; Chueh, Anderly C; Jayachandran, Aparna; Tran, Hoanh; Phesse, Toby; Wu, Rui; Sieber, Oliver M; Arango, Diego; Dhillon, Amardeep S; Dawson, Mark A; Diez-Dacal, Beatriz; Gahman, Timothy C; Filippakopoulos, Panagis; Shiau, Andrew K; Mariadason, John M 
2572-May-2022Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.Weickhardt, Andrew J ; Lau, David K ; Hodgson-Garms, Margeaux; Lavis, Austen; Jenkins, Laura J; Vukelic, Natalia; Ioannidis, Paul; Luk, Ian Y; Mariadason, John M 
258Feb-2017Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patientMurphy, C; Hawkes, E ; Chionh, Fiona; Chong, Geoff
25922-Sep-2023Durable response to combination immunotherapy using nivolumab and ipilimumab in metastatic succinate dehydrogenase (SDH)-deficient gastrointestinal stroma tumour.Klein, Oliver ; Palmer, Jodie ; Behren, Andreas; Cebon, Jonathan S ; Kee, Damien 
260Sep-2020Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.Nowak, Anna K; Lesterhuis, W Joost; Kok, Peey-Sei; Brown, Chris; Hughes, Brett Gm; Karikios, Deme J; John, Thomas ; Kao, Steven C-H; Leslie, Connull; Cook, Alistair M; Pavlakis, Nick; Briscoe, Karen; O'Byrne, Kenneth J; Karapetis, Christos S; Lam, Wei-Sen; Langford, Ailsa; Yip, Sonia; Stockler, Martin R